These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9973758)

  • 41. Primary meningococcal pericarditis.
    Baevsky RH
    Clin Infect Dis; 1999 Jul; 29(1):213-5. PubMed ID: 10433596
    [No Abstract]   [Full Text] [Related]  

  • 42. Thrombolytic therapy in adult meningococcal purpura fulminans with acute renal failure and severe perfusion deficits to the extremities.
    Pechlaner C; Buratti T; Biedermann H; Joannidis M; Wiedermann CJ
    Wien Klin Wochenschr; 1999 Sep; 111(16):650-4. PubMed ID: 10510843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Isoproterenol in the treatment of fulminating meningococcemia in children complicated by shock. An analysis of 181 cases].
    Liu YL
    Zhonghua Yi Xue Za Zhi; 1974; (12):766-70, 214. PubMed ID: 4217259
    [No Abstract]   [Full Text] [Related]  

  • 45. Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score.
    Kornelisse RF; Hazelzet JA; Hop WC; Spanjaard L; Suur MH; van der Voort E; de Groot R
    Clin Infect Dis; 1997 Sep; 25(3):640-6. PubMed ID: 9314453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypokalaemia as a consistent feature of fulminant meningococcal septicaemia.
    Mauger DC
    Aust Paediatr J; 1971 Jun; 7(2):84-6. PubMed ID: 4999188
    [No Abstract]   [Full Text] [Related]  

  • 47. Early treatment with activated protein C for meningococcal septic shock: case report and literature review.
    Hasin T; Leibowitz D; Rot D; Weiss Y; Chajek-Shaul T; Nir-Paz R
    Intensive Care Med; 2005 Jul; 31(7):1002-3. PubMed ID: 15905995
    [No Abstract]   [Full Text] [Related]  

  • 48. [Naloxone hydrochloride in the therapy of endotoxic shock following meningococcal disease. Initial results].
    Martinón JM; Franco A; García JL; Fuster M; Bao A; Martinón F; Peña J
    An Esp Pediatr; 1982 Dec; 17(6):457-60. PubMed ID: 7183216
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chronic meningococcal meningitis: a case report and literature review].
    López Vílchez MA; Fasheh WY
    An Esp Pediatr; 1999 Aug; 51(2):191-3. PubMed ID: 10495509
    [No Abstract]   [Full Text] [Related]  

  • 50. [Shock--continually a current problem].
    Vrhovać B
    Lijec Vjesn; 1973 May; 95(5):269-80. PubMed ID: 4145411
    [No Abstract]   [Full Text] [Related]  

  • 51. Activated protein C for the treatment of fulminant meningococcal septicaemia.
    Thomas GL; Wigmore T; Clark P
    Anaesth Intensive Care; 2004 Apr; 32(2):284-7. PubMed ID: 15957734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Images in clinical medicine. Waterhouse-Friderichsen syndrome.
    Schoeller T; Schmutzhard E
    N Engl J Med; 2001 May; 344(18):1372. PubMed ID: 11333994
    [No Abstract]   [Full Text] [Related]  

  • 53. Systemic meningococcal infection and complement deficiency.
    Leggiadro RJ
    Pediatr Infect Dis J; 2003 Aug; 22(8):760-1. PubMed ID: 12913784
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia.
    Vienne P; Ducos-Galand M; Guiyoule A; Pires R; Giorgini D; Taha MK; Alonso JM
    Clin Infect Dis; 2003 Dec; 37(12):1639-42. PubMed ID: 14689345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neisseria meningitidis endophthalmitis: use of polymerase chain reaction to support an etiologic diagnosis.
    Frelich VS; Murray DL; Goei S; Nussbaum J; Butler H
    Pediatr Infect Dis J; 2003 Mar; 22(3):288-90. PubMed ID: 12664883
    [No Abstract]   [Full Text] [Related]  

  • 56. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.
    Vermont CL; Hazelzet JA; de Kleijn ED; van den Dobbelsteen GP; de Groot R
    Crit Care; 2006 Feb; 10(1):R33. PubMed ID: 16507164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern.
    Mehta G; Goyal R
    J Antimicrob Chemother; 2007 Feb; 59(2):329-30. PubMed ID: 17185299
    [No Abstract]   [Full Text] [Related]  

  • 58. Comment on "Early treatment with activated protein C for meningococcal septic shock: case report and literature review" by Hasin et al.
    Thomas GL; Clark P
    Intensive Care Med; 2005 Dec; 31(12):1729; author reply 1730. PubMed ID: 16283165
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibronectin and meningococcal disease.
    Leclerc F; Cremer R; Leteurtre S; Martinot A; Fourier C
    Eur J Pediatr; 1999 Jan; 158(1):81-2. PubMed ID: 9950316
    [No Abstract]   [Full Text] [Related]  

  • 60. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults.
    Ellis-Pegler R; Galler L; Roberts S; Thomas M; Woodhouse A
    Clin Infect Dis; 2003 Sep; 37(5):658-62. PubMed ID: 12942396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.